However, you don’t have to be an expert in flow cytometry to achieve reproducible and reliable results. Learn everything you need to improve your flow cytometry experiments and gain confidence in your results in less than one hour.

In this webinar, our expert speaker Dr. Ceri Fielding, from the division of infection and immunity at Cardiff University, will discuss the need to understand how viruses interact with NK cells during the development of novel antiviral therapies.

Charge heterogeneity is often a critical quality attribute, which must be monitored throughout the development of a therapeutic protein and during quality control release.

As a cornerstone of genetic analysis in biological research, quantitative PCR (qPCR) and digital PCR (dPCR) are the most sensitive molecular methods to analyze nucleic acids and play a key role in the development of cell and gene therapies (CGT).

These tools are widely used during CGT development for example in biodistribution, pharmacokinetics and pharmacodynamics of the investigational lead molecule. But many samples, including tissues rich in nucleases, lipids and other inhibiting substances and target molecules that are short or contain modified bases, can be challenging to work with. For these types of samples, assay design using advanced strategies, concentration standards, spike-in controls and validated normalization is key for reliable analyses.

In this webinar, Dr. Kubista will present strategies for implementing reliable qPCR and dPCR analysis in CGT development while highlighting best practices for adhering to MIQE and dMIQE guidelines and the recently released ISO standard, ISO 20395:2019.

Design–build–test–learn (DBTL) cycles are commonly used in biotechnology and in natural product discovery as they provide a systemic and efficient framework for the metabolic engineering of microbes.

A novel platform that automates multiomics analyses of microbes could enable faster and better DBLT cycles for your research. In this webinar, the development and validation of the high-throughput, automated platform using model microbial organisms is described, as well as the recent work in applying the platform to cell factory and natural products engineering.

In today’s world, laboratories are constantly pushed to be faster, more effective, more accurate, with less waste and cost. At the same time emerging technologies provide labs with an opportunity to change the way they work today making them more efficient and effective. Leveraging these technologies will determine the success of your lab to evolve into the lab of tomorrow.